Recap: Biodesix Q3 Earnings
Portfolio Pulse from Benzinga Insights
Biodesix (NASDAQ:BDSX) reported its Q3 earnings, beating estimated earnings by 6.67% with an EPS of $-0.14 versus an estimate of $-0.15. Revenue was up $2.38 million from the same period last year. Last quarter, the company beat on EPS by $0.04, which was followed by a 3.9% increase in the share price the next day.
November 07, 2023 | 9:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biodesix's Q3 earnings beat estimates, which could lead to a positive impact on its stock price, as seen in the previous quarter.
Biodesix has reported better than expected earnings for Q3, which is a positive signal for investors. This could lead to an increase in the stock price, as investors may interpret this as a sign of good financial health. This is further supported by the fact that in the previous quarter, when the company beat EPS estimates, the stock price increased by 3.9% the next day.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100